These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6474015)

  • 1. Antibodies to lipid A: occurrence in humans.
    Mattsby-Baltzer I; Alving CR
    Rev Infect Dis; 1984; 6(4):553-7. PubMed ID: 6474015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid A antibody determinations using ELISA on patients at a children's hospital: a preliminary report.
    Marget W; Weiss M; Ruhland B
    Infection; 1983; 11(2):84-6. PubMed ID: 6862638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to lipid A during urinary tract infection.
    Mattsby-Baltzer I; Claësson I; Hanson LA; Jodal U; Kaijser B; Lindberg U; Peterson H
    J Infect Dis; 1981 Oct; 144(4):319-28. PubMed ID: 7288213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoid A antibody titer in the human].
    Marget W
    Infection; 1987; 15(2):142-5. PubMed ID: 3596812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipoid A antibody titer in humans].
    Marget W
    Infection; 1987; 15 Suppl 2():S85-8. PubMed ID: 3610331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-A-antibodies--indicators for the risk of renal scarring in children with urinary tract infection.
    Misselwitz J; Neubert H; Horn A; Erler W
    Acta Paediatr Scand; 1986 Nov; 75(6):982-7. PubMed ID: 3564982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurence, significance and clinical consequences of lipid A antibody titers in patients with urinary tract infection (author's transl)].
    Westenfelder M; Galanos C; Withöft A; Lang G
    Infection; 1977; 5(3):144-8. PubMed ID: 914362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria.
    Nys M; Damas P; Damas F; Joassin L; Demonty J
    Med Microbiol Immunol; 1987; 176(5):257-71. PubMed ID: 3657701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The etiological agent bacteria and the antibodies developed against them in urinary tract infections].
    Koçal N; Atun IH
    Mikrobiyol Bul; 1982 Apr; 16(2):131-42. PubMed ID: 7144623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating lipid A antibodies and their relationship to different clinical conditions of patients with Crohn's disease.
    Kruis W; Schussler P; Weinzierl M
    Hepatogastroenterology; 1987 Jun; 34(3):123-6. PubMed ID: 3610019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of lipid A in the development of pyelonephritis? A hypothesis.
    Marget W; Mar PJ
    Scand J Urol Nephrol Suppl; 1987; 104():93-6. PubMed ID: 3481472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease.
    Kruis W; Schussler P; Weinzierl M; Galanos C; Eisenburg J
    Dig Dis Sci; 1984 Jun; 29(6):502-7. PubMed ID: 6144475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid A antibody titers in pyelonephritis and other gram-negative infections (author's transl)].
    Simon G; Reindke B; Marget W
    Infection; 1974; 2(4):178-84. PubMed ID: 4216585
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic value of serum levels of antibacterial and anti-lipid A antibodies in renal infections].
    Mastrolitti G; Jirillo E; Pace G; Montagna MT; Selvaggi FP; Fumarola D; Schena FP
    Minerva Nefrol; 1981; 28(1):63-6. PubMed ID: 7290511
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum anti-lipid A antibodies in multiple myeloma and Waldenström's macroglobulinaemia.
    Fink PC; Galanos C
    Immunobiology; 1985 Feb; 169(1):1-10. PubMed ID: 3921455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of antibodies against bacterial lipopolysaccharides and lipid A by immunoblotting.
    Fink PC; Bokelmann G; Haeckel R
    Prog Clin Biol Res; 1989; 308():1043-51. PubMed ID: 2780685
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenic properties of lipid A.
    Galanos C; Freudenberg MA; Jay F; Nerkar D; Veleva K; Brade H; Strittmatter W
    Rev Infect Dis; 1984; 6(4):546-52. PubMed ID: 6206544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of vesico-ureteric reflux in development of lipid A antibodies in recurrent urinary tract infections in children--a preliminary study.
    Mar PJ; Marget W; Schneider K; Belohradsky BH; Roos R
    Eur J Pediatr; 1987 Jan; 146(1):51-5. PubMed ID: 3582405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid A antibody titers in Crohn's disease (author's transl)].
    Schüssler P; Kruis W; Marget W
    Klin Wochenschr; 1976 Nov; 54(21):1055-6. PubMed ID: 994458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic significance of antibodies to lipid A in patients with chronic kidney infections].
    Altŭnkova I; Robeva R; Bocheva S; Tsekova D; Neshev Kh
    Vutr Boles; 1989; 28(1):60-5. PubMed ID: 2741442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.